Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
2/2017 not set
Quiet Therapeutics
Quiet Therapeutics Overview
Quiet Therapeutics is a cancer drug discovery and development company that is creating a new generation of cancer therapeutics utilizing its proprietary GAGomer technology to specifically target tumor cells.
The GAGomer therapeutic nanoparticles have the ability to target certain types of cancers that express a biomarker. Once the nanoparticles target the specific cancer cells, they deliver a therapeutic payload that leads to the death of the cancer cells.
This new class of cancer treatment enables the flexibility of delivering a medicine that can kill the cancer cells, block the production of proteins that promote the cancer, or even use the cancer cells own machinery to produce proteins that kill the cancer cells.
Quiet Therapeutics develops a diverse set of DNA, RNA, and small molecule anticancer therapeutics.
Quiet Therapeutics Climate Tech relevance
undefined
Companies you might be interested in
Driven by Finder AI
Latest News
No Data, yet.
Sorry, no content found under this section.
Jan 5, 2015
www.israel21c.org
The nanoparticles coming to attack cancer
#Investment
Jan 15, 2013
www.globes.co.il
Targeted delivery co Quiet Therapeutics raises $5.5m